INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,349 | -29.6% | 304,237 | -19.2% | 0.00% | – |
| Q2 2023 | $168,186 | -60.5% | 376,677 | -27.4% | 0.00% | – |
| Q1 2023 | $425,395 | -78.3% | 518,776 | -58.7% | 0.00% | – |
| Q4 2022 | $1,961,669 | -12.0% | 1,257,479 | -2.7% | 0.00% | – |
| Q3 2022 | $2,229,000 | -52.8% | 1,292,852 | -52.6% | 0.00% | -100.0% |
| Q2 2022 | $4,718,000 | -20.6% | 2,727,089 | +64.8% | 0.00% | 0.0% |
| Q1 2022 | $5,940,000 | +126.5% | 1,654,311 | +214.8% | 0.00% | – |
| Q4 2021 | $2,623,000 | -50.3% | 525,480 | -28.7% | 0.00% | -100.0% |
| Q3 2021 | $5,280,000 | -31.4% | 737,386 | -11.2% | 0.00% | 0.0% |
| Q2 2021 | $7,694,000 | +185.3% | 830,060 | +185.6% | 0.00% | – |
| Q1 2021 | $2,697,000 | -47.2% | 290,591 | -49.6% | 0.00% | -100.0% |
| Q4 2020 | $5,106,000 | -31.5% | 577,082 | -10.2% | 0.00% | 0.0% |
| Q3 2020 | $7,459,000 | +0.7% | 642,986 | +134.0% | 0.00% | -50.0% |
| Q2 2020 | $7,405,000 | +335.1% | 274,757 | +20.1% | 0.00% | – |
| Q1 2020 | $1,702,000 | -62.9% | 228,751 | -83.6% | 0.00% | -100.0% |
| Q4 2019 | $4,592,000 | +1500.0% | 1,391,607 | +891.3% | 0.00% | – |
| Q3 2019 | $287,000 | +5.9% | 140,386 | +52.6% | 0.00% | – |
| Q2 2019 | $271,000 | -43.2% | 92,004 | -28.1% | 0.00% | – |
| Q1 2019 | $477,000 | -50.3% | 127,966 | -46.7% | 0.00% | – |
| Q4 2018 | $960,000 | -44.5% | 240,001 | -22.9% | 0.00% | – |
| Q3 2018 | $1,731,000 | +31.5% | 311,332 | -7.3% | 0.00% | – |
| Q2 2018 | $1,316,000 | -12.0% | 335,850 | +5.8% | 0.00% | – |
| Q1 2018 | $1,495,000 | +18.0% | 317,542 | +3.5% | 0.00% | – |
| Q4 2017 | $1,267,000 | -77.5% | 306,664 | -65.4% | 0.00% | -100.0% |
| Q3 2017 | $5,621,000 | -12.6% | 886,538 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $6,433,000 | -26.4% | 820,420 | -37.9% | 0.00% | +100.0% |
| Q1 2017 | $8,740,000 | -25.3% | 1,320,204 | -21.7% | 0.00% | -50.0% |
| Q4 2016 | $11,696,000 | +107.5% | 1,685,254 | +178.6% | 0.00% | 0.0% |
| Q3 2016 | $5,637,000 | +8.8% | 604,867 | +7.9% | 0.00% | 0.0% |
| Q2 2016 | $5,182,000 | -0.0% | 560,812 | -5.8% | 0.00% | 0.0% |
| Q1 2016 | $5,183,000 | -6.6% | 595,093 | -28.0% | 0.00% | 0.0% |
| Q4 2015 | $5,551,000 | +28.5% | 825,975 | +10.5% | 0.00% | 0.0% |
| Q3 2015 | $4,320,000 | -14.2% | 747,460 | +21.1% | 0.00% | 0.0% |
| Q2 2015 | $5,036,000 | -4.0% | 617,091 | -4.0% | 0.00% | 0.0% |
| Q1 2015 | $5,246,000 | -12.2% | 642,993 | -1.2% | 0.00% | 0.0% |
| Q4 2014 | $5,976,000 | -35.6% | 650,905 | -30.9% | 0.00% | -50.0% |
| Q3 2014 | $9,284,000 | -3.9% | 942,578 | +5.5% | 0.00% | 0.0% |
| Q2 2014 | $9,660,000 | – | 893,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |